Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study

BACKGROUND: Coronavirus Disease 2019 (COVID-19) is an evolving pandemic that urged the need to investigate various antiviral therapies. This study was conducted to compare efficacy and safety outcomes of darunavir-cobicistat versus lopinavir-ritonavir in treating patients with COVID-19 pneumonia. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmekaty, Eman Zeyad I., Alibrahim, Rim, Hassanin, Rania, Eltaib, Sitelbanat, Elsayed, Ahmed, Rustom, Fatima, Mohamed Ibrahim, Mohamed Izham, Abu Khattab, Mohammed, Al Soub, Hussam, Al Maslamani, Muna, Al-Khal, Abdullatif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067693/
https://www.ncbi.nlm.nih.gov/pubmed/35507606
http://dx.doi.org/10.1371/journal.pone.0267884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067693/
https://www.ncbi.nlm.nih.gov/pubmed/35507606
http://dx.doi.org/10.1371/journal.pone.0267884

Ejemplares similares